June 15, 2020

Febrile illness in children younger than 36 months is a concern with potentially serious consequences. Factors suggesting serious infection include poor arousability and increased respiratory effort. Urinary tract infections are the most common serious bacterial infections in…

Acute respiratory distress syndrome is noncardiogenic pulmonary edema that manifests as rapidly progressive dyspnea, tachypnea, and hypoxemia. Diagnostic criteria include onset within one week of a known insult or new or worsening respiratory symptoms, profound hypoxemia…

Long-term complications of retained foreign bodies include chronic pain and neurovascular impairment. Wound exploration and initial imaging with radiography or ultrasonography should be considered before foreign body removal. Although some foreign bodies may be left in place…

In this issue, the Lown Right Care: Reducing Overuse and Underuse department on the pros and cons of anticoagulation for stroke prevention includes a new section called the Patient Perspective.1 We would like to welcome Helen Haskell and John James in their new roles on…

Key clinical questions and their evidence-based answers directly from the journal’s content, written by and for family physicians.

A collaboration between AFP and the Lown Institute promotes a vision of delivering health care that is based on the evidence, balanced in its approach, and focused on the patient.

This PPIP quiz is based on the recommendations of the USPSTF.

A woman presented with redness and pain in her right eye that was achy and associated with watery discharge but no visual changes.

Which patients with symptoms of acute rhinosinusitis have bacterial infection?

Ozenoxacin is an effective and safe topical quinolone treatment for bullous and nonbullous impetigo in patients as young as two months. However, it is expensive and some patients may have limited access because it is only available through a physician or hospital.

The latest update to the Global Initiative for Asthma (GINA) guidelines includes significant changes to treatment recommendations, especially a recommendation against using a short-acting beta2 agonists such as albuterol as sole therapy.

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for cognitive impairment in older adults.

Letters to the Editor from AFP readers regarding previously published articles.